U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Scientist
  6. News & Events (Office of the Chief Scientist)
  7. What’s New for OCS
  8. Office of the Chief Scientist Reorganization
  1. What’s New for OCS

Office of the Chief Scientist Reorganization

Overview

Under the FDA reorganization, implemented October 1, 2024, the Office of the Chief Scientist (OCS) has expanded its purview through the creation of new sub-components and realignment of pre-existing components. These changes to OCS will enhance the Office’s ability to support the research foundation, science, and innovation that underpins FDA’s regulatory mission. All components impacted by the reorganization are shown below in blue within the organization chart and are highlighted below: 

OCS Organization Chart with Sub-Units
This chart outlines the nine (9) sub-components and their sub-units that are a part of the Office of the Chief Scientist.

To download a copy of this organization chart and the functions summaries of OCS and each sub-component, please click here.

 


Main Reorganization Changes

Cross-Cutting Functions

Research and Testing 

Regulation and Coordination 

OCS Immediate Office (IO) Staff

Back to Top